Abbott Wins FDA Approval For 'Low Dose' Non-Rechargeable Spinal Cord Stimulator

Abbott Laboratories Inc. announced the US Food and Drug Administration approved the company's Proclaim XR spinal cord stimulator (SCS) for treating patients with persistent neuropathic pain. The device uses Abbott's proprietary BurstDR technology, which offers patients low-dose pain management and runs on a battery that lasts up to 10 years without recharging, Abbott said.

The system is supported by results of the BurstDR micrOdosing StimuLation in De-novo (BOLD) study, in which 100% of the 24 enrolled patients on a low-energy BurstDR dosing program...